Glyco-engineering for biopharmaceutical production in moss bioreactors.

Glyco-engineering for biopharmaceutical production in moss bioreactors.

Item
http://www.wikidata.org/entity/Q38234961
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.Moss-made pharmaceuticals: from bench to bedside.Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein.Antibodies from plants for bionanomaterials.In vivo assembly of DNA-fragments in the moss, Physcomitrella patens.Extracellular peptidase hunting for improvement of protein production in plant cells and roots.An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice.Plant Glycobiology-a diverse world of lectins, glycoproteins, glycolipids and glycans.Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds.
P2860

Glyco-engineering for biopharmaceutical production in moss bioreactors.

Item
http://www.wikidata.org/entity/Q38234961
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Glyco-engineering for biopharmaceutical production in moss bioreactors.
@en
type
label
Glyco-engineering for biopharmaceutical production in moss bioreactors.
@en
prefLabel
Glyco-engineering for biopharmaceutical production in moss bioreactors.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Glyco-engineering for biopharmaceutical production in moss bioreactors.
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P932